Clinical Trial Update: Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating temsirolimus in combination with gemcitabine for previously untreated metastatic pancreatic cancer; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Torisel (Temsirolimus)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pancreatic Adenocarcinoma | Phase 1 | Status: TERMINATED